Vistagen: Pherine Candidate Proof Of Concept Continues With Fifth Indication
Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...
Earnings call transcript: LiveOne Q3 2024 misses EPS forecast, stock dips
LiveOne Inc. reported its financial results for the third quarter of 2024, revealing a miss on earnings per share (EPS) expectations. The company posted an EPS of -$0.06, falling short of the ...
Earnings call transcript: Sensient Technologies Q4 2024 revenue growth
Sensient Technologies Corporation reported its financial results for the fourth quarter of 2024, revealing a slight miss in earnings per share (EPS) compared to forecasts. Despite this, revenue ...
We Need To Talk About Luther Vandross’s Cashmere Walls
In his lifetime, Luther Vandross was nominated for 31 Grammy awards, winning eight. He dominated the R&B charts and wedding ...